MLchartDataset catalogue

Liposomal interleukin-2

Term · Oncology and biomedicine · MLC-T-ONC-014823

A formulation in which liposomes are loaded with the cytokine interleukin-2 (IL-2). By activating cytotoxic T lymphocytes, such as lymphokine-activated killer cells, and increasing levels of the cytotoxic cytokines interferon-gamma (IFN-gamma) and transforming growth factor-beta (TGF-beta), IL-2 may exhibit antitumoral activity. Liposomal formulations of IL-2 may promote entry of the cytokine into target tumor cells and may be used as an immunoadjuvant in cancer vaccine therapy.

Table 1. Record
IdentifierMLC-T-ONC-014823
FieldOncology and biomedicine
AbbreviationIL-2 LIPO
Synonymsinterleukin-2 liposome; liposome encapsulated interleukin-2
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-014823",
  "term": "Liposomal interleukin-2",
  "field": "Oncology and biomedicine",
  "definition": "A formulation in which liposomes are loaded with the cytokine interleukin-2 (IL-2). By activating cytotoxic T lymphocytes, such as lymphokine-activated killer cells, and increasing levels of the cytotoxic cytokines interferon-gamma (IFN-gamma) and transforming growth factor-beta (TGF-beta), IL-2 may exhibit antitumoral activity. Liposomal formulations of IL-2 may promote entry of the cytokine into target tumor cells and may be used as an immunoadjuvant in cancer vaccine therapy.",
  "abbreviation": "IL-2 LIPO",
  "synonyms": [
    "interleukin-2 liposome",
    "liposome encapsulated interleukin-2"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/liposomal-interleukin-2/"
}

Record 10,174 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.